EGFR and non-small cell lung carcinoma: To address the involvement of transcriptional adaptation in YAP-mediated drug tolerance, we developed isogenic EGFR-mutant NSCLC cell lines and introduced genetic barcodes of intermediate complexity (totaling 725 barcode groups) to track clonal transition and transcriptional states during the development of the DTP state.